Out now: our new and updated DeSci Landscape!!
Many new projects have been added since our last update.
We aggregate data from the DeSci Wiki, so if your project is missing or needs to be updated, make sure to comment in the doc linked below.
Out now: our new and updated DeSci Landscape!!
Many new projects have been added since our last update.
We aggregate data from the DeSci Wiki, so if your project is missing or needs to be updated, make sure to comment in the doc linked below.
🌐 We're excited to announce the FIRST #DeSci JOB BOARD! 🌐
Whether you're looking to build your team or participate more in the growing space, our platform is here to condense these opportunities and make it an easy process.
Check it out now on desci.world/jobs
Great article about putting patients first when it comes to drug development. There are a few companies out there who are doing this.
Exciting times for the patient communities who have put so much into finding their cures. open.substack.com/pub/perlar…
by @PerlaraPBC / @eperlste
New Episode Alert 📣
Learn from mom, scientist and rare disease advocate Dr. @MadeleineOudin! We talk about her path to academia, her research studying cancer and neuroscience and more!
Link: youtu.be/MBlCAMOVhTA
Also available wherever you listen to podcasts.
Perlara 'walks the walk' of decentralized science, sharing their cure roadmaps with the public so that other rare disease families can learn from this important work! Check out all ten of the roadmaps in the link below 👇
cc @PerlaraPBC@eperlste
It's here! Your brand new DeSci Landscape!
Updated 10/14/2022 by @danielyse_ and @JocelynnPearl input from the community.
And once again we're seeing an amazing expansion of DAOs, projects, and categories.
Let's check out who's here 👀
Susannah, a nano-rare child, receives personalized medicine with the hopes to halt her neurodegenerative disorder. Her experimental medicine was created by n-Lorem to address her unique genetic mutation; the ultimate in personalized medicine. NYT exclusive linktr.ee/nlorem
I founded @PerlaraPBC in 2014 as the first biotech PBC.
9 years 2 pivots later the business is not only profitable but growing and the first patient in a Phase 3 pivotal study sponsored by our first joint venture and family-led biotech @epalrestat will be dosed next week. 🧵👇
Mark your calendars for November 17th at 5pm PT / 8pm ET for a @Web3WomenInSci SciArt Happy Hour with @UltraRareBio!!
Join us for a night of science-inspired painting 🎨, drawing, drinks 🍸, and catching up before the holidays pick up!
discord.com/invite/P7kPtqRfJ…